临床试验：0N01910NA 与伊立替汀或奥沙利铂在高级固体中-猫眼课题宝

临床试验：0N01910NA 与伊立替汀或奥沙利铂在高级固体中

批准号：

7953731

负责人：

TAKAO OHNUMA

金额：

$1.25万

依托单位：

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

依托单位国家：

美国

项目类别：

财政年份：

2009

资助国家：

美国

项目状态：

已结题

起止时间：

2009-03-01 至 2009-07-31

来源：

https://reporter.nih.gov/project-details/7953731

关键词：

Antineoplastic Agents Clinical Research Clinical Trials Computer Retrieval of Information on Scientific Projects Database Funding Grant Institution Research Research Personnel Resources Solid Source Therapeutic Effect Toxic effect United States National Institutes of Health improved irinotecan oxaliplatin

项目摘要

项目成果

TAKAO OHNUMA的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypothesis: Addition of an investigational agent ON 01910.Na to currently available anticancer agent, oxaliplatin or irinotecan improves therapeutic effects of oxaliplatin or irinotecan without added toxicity.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文